Clinical Trial Update: Avexitide for Treatment of Post-Bariatric Hypoglycemia [Phase 3]

View source ↗

Summary

Avexitide is in Phase 3 trials for post-bariatric hypoglycemia; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-bariatric Hypoglycemia

Drugs mentioned

• Avexitide

Snippet

Sponsor: Amylyx Pharmaceuticals Inc. | Conditions: Post Bariatric Hypoglycemia | Phase 3 | Status: ACTIVE_NOT_RECRUITING